Your browser doesn't support javascript.
loading
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Egelston, Colt A; Guo, Weihua; Yost, Susan E; Ge, Xuan; Lee, Jin Sun; Frankel, Paul H; Cui, Yujie; Ruel, Christopher; Schmolze, Daniel; Murga, Mireya; Tang, Aileen; Martinez, Norma; Karimi, Misagh; Somlo, George; Lee, Peter P; Waisman, James R; Yuan, Yuan.
Affiliation
  • Egelston CA; Department of Immuno-Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Guo W; Department of Immuno-Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Yost SE; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Ge X; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Lee JS; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Frankel PH; Department of Statistics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Cui Y; Department of Statistics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Ruel C; Department of Statistics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Schmolze D; Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Murga M; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Tang A; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Martinez N; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Karimi M; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Somlo G; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Lee PP; Department of Immuno-Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Waisman JR; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Yuan Y; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Yuan.Yuan@cshs.org.
Cancer Immunol Immunother ; 72(9): 3013-3027, 2023 Sep.
Article de En | MEDLINE | ID: mdl-37294342
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein triple-négatives Limites: Humans Langue: En Journal: Cancer Immunol Immunother Sujet du journal: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein triple-négatives Limites: Humans Langue: En Journal: Cancer Immunol Immunother Sujet du journal: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Allemagne